BioCryst Pharmaceuticals Announces Upcoming Conferences
![BioCryst Pharmaceuticals Announces Upcoming Conferences](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
BioCryst Pharmaceuticals Announces Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) has confirmed that it will present at several prominent investor conferences in the healthcare sector. These events are essential for showcasing the company’s advancements and commitment to addressing rare diseases through innovative treatments.
Details of Upcoming Conferences
The company will participate in the following key events:
Wells Fargo Healthcare Conference
BioCryst is set to present at the 2024 Wells Fargo Healthcare Conference, scheduled for Thursday, September 5, 2024, at 1:30 p.m. ET. This conference is a significant gathering for investors and representatives from the biotech and pharmaceutical sectors to discuss advancements and future potential.
H.C. Wainwright 26th Annual Global Investment Conference
Following that, the company will be featured at the H.C. Wainwright 26th Annual Global Investment Conference, occurring on Monday, September 9, 2024, at 9:00 a.m. ET. This conference is a platform for companies to present their bio-pharmaceutical strategies and growth prospects.
Cantor Global Healthcare Conference
Additionally, BioCryst will participate in the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024, at 12:45 p.m. ET. This event provides attendees with insights into ongoing innovations and the potential market impact of the latest therapeutic developments tailored for rare diseases.
Accessing Conference Presentations
Investors and interested parties can access live audio webcasts of the presentations as well as replays through the Investor Relations section of BioCryst’s official website. This feature allows stakeholders who cannot attend the conferences in person to stay informed about the company's latest developments and presentations.
About BioCryst Pharmaceuticals
BioCryst Pharmaceuticals is a biotechnology firm that focuses on developing innovative solutions for complement-mediated and other rare diseases. The company specializes in structure-guided drug design, enabling the creation of first-in-class or best-in-class therapeutic agents. One of its notable products, ORLADEYO (berotralstat), is recognized as the first oral, once-daily plasma kallikrein inhibitor aimed at improving treatment options for patients.
With a robust pipeline of small-molecule and protein therapies, BioCryst is committed to addressing unmet medical needs in the challenging field of rare diseases. The company's focus on both commercializing existing therapies and advancing new candidates reflects its dedication to enhancing patients’ lives worldwide.
Contact Information
For further inquiries, please reach out to:
John Bluth
+1 919 859 7910
jbluth@biocryst.com
Frequently Asked Questions
What is the purpose of BioCryst's presentations at these conferences?
The presentations aim to showcase BioCryst's innovative therapies and engage with investors about the company’s growth and strategic direction in treating rare diseases.
How can interested parties access the conference presentations?
Investors can access live audio webcasts and replays of the presentations via the Investor Relations section of BioCryst's official website.
What is ORLADEYO (berotralstat)?
ORLADEYO is BioCryst's first oral, once-daily plasma kallikrein inhibitor, designed to provide new treatment options for patients suffering from rare diseases related to complement system dysfunction.
What is the significance of the H.C. Wainwright Conference?
This is an annual event where leading companies in the biotechnology and healthcare sectors present their innovations and strategic insights to potential investors and stakeholders.
Who should be contacted for further inquiries about BioCryst?
For further inquiries, interested individuals can contact John Bluth at the provided phone number or email.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Related Articles
- ProVen Growth and Income VCT plc Announces Fundraising Plans
- Nuwellis Announces $916,000 Registered Direct Offering
- Gabelli Global Utility & Income Trust Announces Monthly Distributions
- The GDL Fund Announces Third Quarter Distribution of $0.12
- Gabelli Global Small and Mid Cap Value Trust Announces Q3 Distribution
- GAMCO Global Gold Trust Announces Monthly Distributions
- Gabelli Utility Trust Announces Monthly Distributions Plan
- Gabelli Healthcare & WellnessRx Trust Announces $0.15 Distribution
- Gabelli Convertible Fund Announces $0.12 Distribution
- Repligen Corporation's Upcoming Presentation at Healthcare Conference